Durgam Suresh K.
Officer at ITCI
- Sold, on record
- $10.1M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Mar 11, 2024
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ITCIIntra-Cellular Therapies, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ITCIUnusualJan 2, 2024 2024
Sold 62,282 shares at $70.60 ($4.4M)
Durgam Suresh K., EVP, Chief Medical Officer
10b5-1 planSold 100% of holdings ($4.4M position)0 shares left8.8x usual sizeFollows a Form 144Filing
- 2 Form 144 notice ITCINoticeFeb 2, 2024 +31 days
Filed to sell 6,167 shares ($414k)
Durgam Suresh K., Officer
10b5-1 plan0.8x usual sizeFiling
- 3 Form 4 sale ITCIRoutineFeb 2, 2024 same day
Sold 6,167 shares at $67.19 ($414k)
Durgam Suresh K., EVP, Chief Medical Officer
10b5-1 planSold 52% of holdings ($797k position)5,693 shares left0.8x usual sizeFollows a Form 144Filing
- 4 Form 144 notice ITCINoticeFeb 26, 2024 +24 days
Filed to sell 4,112 shares ($288k)
Durgam Suresh K., Officer
10b5-1 plan0.5x usual sizeFiling
- 5 Form 4 sale ITCIRoutineFeb 26, 2024 same day
Sold 4,112 shares at $70.17 ($289k)
Durgam Suresh K., EVP, Chief Medical Officer
10b5-1 planSold 30.2% of holdings ($954k position)9,488 shares left0.5x usual sizeFollows a Form 144Filing
- 6 Form 144 notice ITCINoticeMar 7, 2024 +10 days
Filed to sell 6,450 shares ($429k)
Durgam Suresh K., Officer
10b5-1 plan0.8x usual sizeFiling
- 7 Form 144 notice ITCINoticeMar 11, 2024 +4 days
Filed to sell 3,712 shares ($243k)
Durgam Suresh K., Officer
10b5-1 plan0.5x usual sizeFiling
- 8 Form 4 sale ITCIRoutineMar 11, 2024 same day
Sold 10,162 shares at $66.21 ($673k)
Durgam Suresh K., EVP, Chief Medical Officer
10b5-1 planSold 33.9% of holdings ($2M position)19,803 shares left1.3x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (23)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Mar 11, 2024 | ITCI | EVP, Chief Medical Officer | Form 4 sale | 10,162 | $673k | 33.9% | Routine | SEC |
| Mar 11, 2024 | Mar 11, 2024 | ITCI | Officer | Form 144 notice | 3,712 | $243k | Notice | SEC | |
| Mar 7, 2024 | Mar 7, 2024 | ITCI | Officer | Form 144 notice | 6,450 | $429k | Notice | SEC | |
| Feb 26, 2024 | Feb 27, 2024 | ITCI | EVP, Chief Medical Officer | Form 4 sale | 4,112 | $289k | 30.2% | Routine | SEC |
| Feb 26, 2024 | Feb 26, 2024 | ITCI | Officer | Form 144 notice | 4,112 | $288k | Notice | SEC | |
| Feb 2, 2024 | Feb 5, 2024 | ITCI | EVP, Chief Medical Officer | Form 4 sale | 6,167 | $414k | 52.0% | Routine | SEC |
| Feb 2, 2024 | Feb 2, 2024 | ITCI | Officer | Form 144 notice | 6,167 | $414k | Notice | SEC | |
| Jan 2, 2024 | Jan 4, 2024 | ITCI | EVP, Chief Medical Officer | Form 4 sale | 62,282 | $4.4M | 100.0% | Unusual | SEC |
| Jan 2, 2024 | Jan 2, 2024 | ITCI | Officer | Form 144 notice | 62,282 | $4.4M | Notice | SEC | |
| Dec 13, 2023 | Dec 15, 2023 | ITCI | EVP, Chief Medical Officer | Form 4 sale | 21,262 | $1.4M | 100.0% | Unusual | SEC |
| Dec 13, 2023 | Dec 13, 2023 | ITCI | Officer | Form 144 notice | 21,262 | $1.4M | Notice | SEC | |
| Jul 17, 2023 | Jul 20, 2023 | ITCI | EVP, Chief Medical Officer | Form 4 sale | 1,842 | $120k | 8.0% | Routine | SEC |
| Jul 17, 2023 | Jul 17, 2023 | ITCI | Officer | Form 144 notice | 1,842 | $120k | Notice | SEC | |
| Mar 13, 2023 | Mar 13, 2023 | ITCI | EVP, Chief Medical Officer | Form 4 sale | 7,344 | $331k | 24.1% | Plan not stated | SEC |
| Feb 24, 2023 | Feb 27, 2023 | ITCI | SVP, Chief Medical Officer | Form 4 sale | 7,906 | $373k | 25.5% | Unusual | SEC |
| Feb 21, 2023 | Feb 22, 2023 | ITCI | SVP, Chief Medical Officer | Form 4 sale | 8,354 | $391k | 26.6% | Unusual | SEC |
| Mar 4, 2022 | Mar 4, 2022 | ITCI | Chief Medical Officer | Form 4 sale | 8,037 | $452k | 25.8% | Unusual | SEC |
| Feb 24, 2022 | Feb 25, 2022 | ITCI | Chief Medical Officer | Form 4 sale | 4,046 | $211k | 11.5% | Plan not stated | SEC |
| Feb 22, 2022 | Feb 23, 2022 | ITCI | Chief Medical Officer | Form 4 sale | 4,177 | $231k | 13.3% | Plan not stated | SEC |
| Jan 18, 2022 | Jan 20, 2022 | ITCI | Chief Medical Officer | Form 4 sale | 6,223 | $262k | 21.2% | Plan not stated | SEC |
| Jan 10, 2022 | Jan 11, 2022 | ITCI | Chief Medical Officer | Form 4 sale | 6,870 | $280k | 19.0% | Plan not stated | SEC |
| Feb 19, 2021 | Feb 22, 2021 | ITCI | Chief Medical Officer | Form 4 sale | 2,734 | $107k | 10.6% | Plan not stated | SEC |
| Jan 11, 2021 | Jan 12, 2021 | ITCI | Chief Medical Officer | Form 4 sale | 4,367 | $140k | 20.0% | Plan not stated | SEC |